call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Companion Diagnostics Market Report
Inquire Before Buying Request for Sample

Companion Diagnostics Market Report

Home Healthcare And Pharmaceutical Companion Diagnostics Market Report

Companion Diagnostics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product & Service (Assays, Kits & Reagents, Software & Services); By Technology (Polymerase Chain Reaction, Next-generation Sequencing, In-Situ Hybridization, Immunohistochemistry); By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical & Biopharmaceutical, Reference Laboratories, Contract Research Organizations); By Region (North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA))

  • Published Date: February 2023
  • Report ID: BWC20380
  • Available Format: PDF
  • Page: 400

Report Overview

Increasing cases of adverse drug reactions and co-development of drug and diagnostic technology are projected to propel the expansion of global companion diagnostics market during the forecast period between 2023 and 2029.

Global Companion Diagnostics Market - Industry Trends & Forecast Report, 2029

Global companion diagnostics market size was estimated at USD 6.12 billion in 2022. During the forecast period between 2023 and 2029, the size of global companion diagnostics market is projected to grow at CAGR of 12.15% reaching a value of USD 13.57 billion by 2029. Major growth drivers for global companion diagnostics market include increasing requirement for personalized treatment, broad application areas of companion diagnostics, surging demand for focused therapy, growing cancer occurrences, and development of new biomarkers for various illnesses. Personalized medicine is becoming increasingly popular as the field of genetics and genetic engineering expands fast. It is now possible to provide the correct medicine to the right individual at the right time based on a person's genetic features. As part of a patient-centric drug development approach, many pharmaceutical and biopharmaceutical companies are developing targeted medication therapies. Numerous third-party companion diagnostic services provide similar services to enterprises that face a greater financial strain. As a result, the issue of high startup expenses has been effectively handled. These reasons are projected to drive the companion diagnostics market during the forecast period.

Global Companion Diagnostics Market

Global Companion Diagnostics Market – Overview

A companion diagnostics device is a medical gadget that is used in conjunction with therapeutic medications to assess the effect and applicability of drugs on a specific human body. Companion diagnostics are developed in tandem with medications to select or exclude patient groups based on the features to which they respond to therapy. This device assists the healthcare provider in determining whether a specific treatment is beneficial to the patient. In 2020, Roche gained FDA approval for Cobas EGFR Mutation Test v2 companion diagnostic for EGFR tyrosine kinase inhibitor for lung cancer treatment. Companion Diagnostic (CDx) is a clinical test created in collaboration with a therapeutic medicine to identify responders and non-responders to that therapy. It is done to determine which patient groups may and cannot be treated with the relevant medicine. CDx assists practitioners in determining the benefits, side effects, and hazards connected with therapeutic drug intake, guaranteeing patient safety. Growing patient preferences for customized therapy, expanding applications of personalized medications, increased prevalence of chronic diseases, and rising occurrences of allergies in patients as a result of medication adverse effects all contribute to the development of customized CDx, propelling the global Companion Diagnostics Market forward. Furthermore, CDx tests' features, such as cost-effectiveness, high sensitivity, and rapid and precise results in short timeframes, aid in the expansion of the companion diagnostics market.

Global Companion Diagnostics Market

Growth Drivers

Rapid Adoption of Technology Advancements

The companion indicative tests based on next-generation sequencing intend to open nuclear information from each persistent development genome to coordinate treatment decisions for disease medicines. When compared to previous sequencing technologies, forward sequencing detects more biomarkers for diverse drugs in a shorter period of time. The use of NGS sheets for biomarker assessment in a single test may aid in the treatment of a wide range of disorders. The many inventive degrees of improvement in NGS also give market participants a quick advantage over players providing other advancements such as PCR, ICH, and ISH. As a result, key market participants are concentrating on creating amigo illustrative goods in light of NGS.

Restraints

Expensive & Underutilized Companion Diagnostic Approaches

While immunotherapy has demonstrated a vital guarantee in cancer treatment, its high cost has limited widespread availability. Doctors may prefer to combine therapies, which could increase the length of the treatment from five months to more than three years. In this case, the longer the time, the more noticeable the cost. Also, the cost of personalized immunotherapies is significant. Disease immunotherapies can be significantly more expensive than other treatment options, like as chemotherapy or radiation therapy. As a result, the high cost of immuno-oncology treatments is expected to stymie the growth of the companion diagnostics industry.

Impact of COVID-19 on Global Companion Diagnostics Market

COVID-19 had a detrimental impact on the companion diagnostics market. In addition, prominent market participants witnessed a considerable drop in income owing to a fall in testing volume and other variables. In terms of sales, the market grew by 15.1% in 2020, compared to 19.8% in 2019. Revenue generated by the major players decreased significantly in 2020. However, the lifting of lockdown restrictions, stay-at-home orders in many nations, the introduction of novel diagnostic tests, and the re-establishment of the supply chain network were major contributors in the recovery of testing in 2021. As a result, the restart of cancer diagnostics testing and the introduction of novel diagnostic tests boosted demand in 2021.

Global Companion Diagnostics Market

Segmental Coverage

Global Companion Diagnostics Market – By Product & Service

By product & service, global companion diagnostics market is bifurcated into Assays, Kits & Reagents and Software & Services segments. The assays, kits, and reagents segment held the highest market share in 2020, owing to the availability of a diverse product portfolio and the rising use of assays and kits in many therapeutic areas.

Companion Diagnostics Market Size

Global Companion Diagnostics Market – By Technology

Based on technology, global companion diagnostics market is divided into Polymerase Chain Reaction, Next-generation Sequencing, In Situ Hybridization, and Immunohistochemistry. The Polymerase Chain Reaction (PCR) segment dominates the market and is expected to develop throughout the forecast period. Cost-effectiveness, high sensitivity, and specificity are key factors driving market growth, and they may be used to basic automated systems. Additionally, PCR, another important driver of this section, can determine the sequencing of many diseases' unknown etiology. Furthermore, the next-generation sequencing segment is expected to grow rapidly during the forecast period owing to higher sensitivity to identify low-frequency variants, quicker turnaround duration for large sample volumes, the ability to sequence hundreds to thousands of genes or gene regions concurrently.

Global Companion Diagnostics Market – By Indication

Based on indication, global companion diagnostics market is divided into Cancer, Neurological Disorders, Cardiovascular Diseases, and Infectious Diseases. In 2022, the cancer segment held the highest market share. Increased cancer prevalence, an increase in the number of cancer R&D activities, an increase in the number of unmet needs for cancer treatment, an increase in the number of FDA-approved companion diagnostics, and increased patient awareness about personalized medicine are some of the key factors driving the growth of the oncology segment. The cancer segment includes lung cancer, breast cancer, blood cancer, and colorectal cancer. Amongst them, lung cancer holds the highest market share. Companion diagnostic tests (CDXs) are regarded mandatory in the decision-making process for lung cancer treatment with targeted treatments. Individuals with lung cancer who undergo companion diagnostics as part of their initial treatment have a higher chance of surviving than those who do not. Globally, the increasing incidence rate of non-small cell lung cancer (NSCLC), combined with an increase in the development of oncology companion diagnostic tests for the disease, is likely to drive sector growth.

Global Companion Diagnostics Market – By End User

Based on end user, global companion diagnostics market is segmented into Pharmaceutical & Biopharmaceutical, Reference Laboratories, and Contract Research Organizations. In 2022, the pharmaceutical and biopharmaceutical industry held a majority share in the market. The increasing importance of companion diagnostic biomarkers, as well as the growing usage of companion diagnostics in drug development.

Global Companion Diagnostics Market – By Region

Regionally, global companion diagnostics market is segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America had a sizable market share in 2022 and is expected to expand throughout the forecast period. The high prevalence of various forms of malignancies among the American population drives the North American market. In Canada, the number of cancer patients is increasing over time. As stated by the Canadian Cancer Society, cancer accounts for around 28.2% of all fatalities in Canada. Also, the number of patients with cancer in Mexico is increasing, resulting in increased costs to the country per capita each year. According to the Pan American Health Organization, Mexico had 190,667 cancer cases, with 83,476 cancer patients dying. According to the American Society of Clinical Oncology, the number of cancer cases in Mexico will climb to 1,262,861 over the next decade. Asia Pacific offers significant opportunities for key participants in the companion diagnostics market due to its huge population base, rising awareness of companion diagnostics, development of healthcare infrastructure, and growing demand for advanced treatments.

Competitive Landscape

Major players operating in global companion diagnostics market include Abbott Laboratories Inc., Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Biomerieux SA, Qiagen NV, Siemens Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter Inc.), Almac Group, Illumina Inc., Myriad Genetics Inc., Sysmex Corporation, Abnova Corporation, and Guardant Health Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In May 2021 - Amgen Inc., QIAGEN N.V. officially confirmed the expansion of companion diagnostic (CDx) claims for the therascreen KRAS RGQ PCR Kit (therascreen KRAS Kit) (AMGN) following regulatory approval in the United States as a companion diagnostic to assist in the detection of non-small cell lung cancer (NSCLC) patients who may be qualified for treatment with LUMAKRASTM (sotorasib).

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Billion

Market Coverage

North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)

Product/ Service Segmentation

Product & Service, Technology, Indication, End User, Region

Key Players

Abbott Laboratories Inc., Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Biomerieux SA, Qiagen NV, Siemens Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter Inc.), Almac Group, Illumina Inc., Myriad Genetics Inc., Sysmex Corporation, Abnova Corporation, Guardant Health Inc.

 

By Product & Service

  • Assays, Kits & Reagents

  • Software & Services

By Technology

  • Polymerase Chain Reaction

  • Next-generation Sequencing

  • In Situ Hybridization

  • Immunohistochemistry

By Indication

  • Cancer

  • Neurological Disorders

  • Cardiovascular Diseases

  • Infectious Diseases

By End User

  • Pharmaceutical & Biopharmaceutical Companies

  • Reference Laboratories

  • Contract Research Organizations

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Companion Diagnostics Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Increasing Cases of Adverse Drug Reactions
        2. Co-development of Drug and Diagnostic Technology
      2. Restraints
        1. High Cost of Drug Development and Associated Clinical Trials
      3. Opportunities
        1. Rising Demand for Next Generation Sequencing
      4. Challenges
        1. Reimbursement Issues Among Many Countries
    3. Technology Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Companion Diagnostics Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product & Service
        1. Assays, Kits & Reagents
        2. Software & Services
      2. By Technology
        1. Polymerase Chain Reaction
        2. Next-generation Sequencing
        3. In Situ Hybridization
        4. Immunohistochemistry
        5. Others
      3. By Indication
        1. Cancer
          1. Lung Cancer
          2. Breast Cancer
          3. Blood Cancer
          4. Colorectal Cancer
          5. Others
        2. Neurological Disorders
        3. Cardiovascular Diseases
        4. Infectious Diseases
        5. Others
      4. By End User
        1. Pharmaceutical & Biopharmaceutical
        2. Reference Laboratories
        3. Contract Research Organizations
        4. Others
      5. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Companion Diagnostics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
      5. By Country
        1. US
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        2. Canada
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
  6. Europe Companion Diagnostics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
      5. By Country
        1. Germany
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        2. UK
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        3. Italy
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        4. France
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        5. Spain
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        6. The Netherlands
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        7. Rest of Europe
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
  7. Asia-Pacific Companion Diagnostics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
      5. By Country
        1. China
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        2. India
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        3. Japan
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        4. South Korea
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        5. Australia & New Zealand
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        6. Indonesia
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        7. Malaysia
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        8. Singapore
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        9. Philippines
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        10. Vietnam
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        11. Rest of APAC
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
  8. Latin America Companion Diagnostics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
      5. By Country
        1. Brazil
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        2. Mexico
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        3. Argentina
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        4. Peru
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        5. Rest of LATAM
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
  9. Middle East & Africa Companion Diagnostics Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
      5. By Country
        1. Saudi Arabia
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        2. UAE
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        3. Qatar
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        4. Kuwait
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        5. South Africa
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        6. Nigeria
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        7. Algeria
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
        8. Rest of MEA
          1. By Product & Service
          2. By Technology
          3. By Indication
          4. By End User
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Companion Diagnostics Company Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Companion Diagnostics Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Abbott Laboratories Inc.
    2. Agilent Technologies Inc.
    3. F. Hoffmann-La Roche Ltd
    4. Biomerieux SA
    5. Qiagen NV
    6. Siemens Healthcare
    7. Thermo Fisher Scientific Inc.
    8. Danaher Corporation (Beckman Coulter Inc.)
    9. Almac Group
    10. Illumina Inc.
    11. Myriad Genetics Inc.
    12. Sysmex Corporation
    13. Abnova Corporation
    14. Guardant Health Inc
    15. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.  Qualitative Research
      1.  Primary & Secondary Research
    2.  Quantitative Research
    3.  Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.  Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

 

List of Figures

 

Figure 1       Global Companion Diagnostics Segmentation

Figure 2       Global Companion Diagnostics Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       Global Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 5       Global Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 6       Global Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 7       Global Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 8       Global Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 9       Global Companion Diagnostics Market Share, By Region, By Value, 2019–2029

Figure 10     North America Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 11     North America Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 12     North America Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 13     North America Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 14     North America Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 15     North America Companion Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 16     US Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 17     US Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 18     US Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 19     US Companion Diagnostics Market Share, By Flow Rate, By Value, 2019–2029

Figure 20     US Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 21     Canada Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 22     Canada Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 23     Canada Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 24     Canada Companion Diagnostics Market Share, By Flow Rate, By Value, 2019–2029

Figure 25     Canada Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 26     Europe Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 27     Europe Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 28     Europe Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 29     Europe Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 30     Europe Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 31     Europe Companion Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 32     Germany Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 33     Germany Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 34     Germany Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 35     Germany Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 36     Germany Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 37     UK Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 38     UK Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 39     UK Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 40     UK Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 41     UK Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 42     Italy Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 43     Italy Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 44     Italy Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 45     Italy Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 46     Italy Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 47     France Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 48     France Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 49     France Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 50     France Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 51     France Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 52     Spain Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 53     Spain Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 54     Spain Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 55     Spain Companion Diagnostics Market Share, By Flow Rate, By Value, 2019–2029

Figure 56     Spain Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 57     The Netherlands Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 58     The Netherlands Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 59     The Netherlands Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 60     The Netherlands Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 61     The Netherlands Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 62     Rest of Europe Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 63     Rest of Europe Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 64     Rest of Europe Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 65     Rest of Europe Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 66     Rest of Europe Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 67     Asia-Pacific Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 68     Asia-Pacific Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 69     Asia-Pacific Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 70     Asia-Pacific Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 71     Asia-Pacific Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 72     Asia-Pacific Companion Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 73     China Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 74     China Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 75     China Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 76     China Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 77     China Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 78     India Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 79     India Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 80     India Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 81     India Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 82     India Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 83     Japan Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 84     Japan Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 85     Japan Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 86     Japan Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 87     Japan Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 88     South Korea Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 89     South Korea Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 90     South Korea Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 91     South Korea Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 92     South Korea Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 93     Australia & New Zealand Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 94     Australia & New Zealand Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 95     Australia & New Zealand Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 96     Australia & New Zealand Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 97     Australia & New Zealand Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 98     Indonesia Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 99     Indonesia Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 100   Indonesia Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 101   Indonesia Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 102   Indonesia Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 103   Malaysia Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 104   Malaysia Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 105   Malaysia Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 106   Malaysia Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 107   Malaysia Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 108   Singapore Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 109   Singapore Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 110   Singapore Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 111   Singapore Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 112   Singapore Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 113   Philippines Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 114   Philippines Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 115   Philippines Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 116   Philippines Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 117   Philippines Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 118   Vietnam Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 119   Vietnam Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 120   Vietnam Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 121   Vietnam Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 122   Vietnam Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 123   Rest of APAC Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 124   Rest of APAC Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 125   Rest of APAC Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 126   Rest of APAC Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 127   Rest of APAC Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 128   Latin America Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 129   Latin America Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 130   Latin America Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 131   Latin America Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 132   Latin America Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 133   Latin America Companion Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 134   Brazil Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 135   Brazil Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 136   Brazil Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 137   Brazil Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 138   Brazil Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 139   Mexico Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 140   Mexico Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 141   Mexico Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 142   Mexico Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 143   Mexico Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 144   Argentina Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 145   Argentina Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 146   Argentina Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 147   Argentina Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 148   Argentina Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 149   Peru Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 150   Peru Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 151   Peru Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 152   Peru Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 153   Peru Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 154   Rest of LATAM Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 155   Rest of LATAM Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 156   Rest of LATAM Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 157   Rest of LATAM Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 158   Rest of LATAM Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 159   Middle East & Africa Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 160   Middle East & Africa Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 161   Middle East & Africa Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 162   Middle East & Africa Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 163   Middle East & Africa Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 164   Middle East & Africa Companion Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 165   Saudi Arabia Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 166   Saudi Arabia Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 167   Saudi Arabia Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 168   Saudi Arabia Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 169   Saudi Arabia Companion Diagnostics Market Share, By Distribution Indication, By Value, 2019–2029

Figure 170   UAE Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 171   UAE Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 172   UAE Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 173   UAE Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 174   UAE Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 175   Qatar Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 176   Qatar Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 177   Qatar Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 178   Qatar Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 179   Qatar Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 180   Kuwait Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 181   Kuwait Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 182   Kuwait Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 183   Kuwait Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 184   Kuwait Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 185   South Africa Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 186   South Africa Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 187   South Africa Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 188   South Africa Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 189   South Africa Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 190   Nigeria Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 191   Nigeria Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 192   Nigeria Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 193   Nigeria Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 194   Nigeria Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 195   Algeria Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 196   Algeria Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 197   Algeria Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 198   Algeria Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 199   Algeria Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 200   Rest of MEA Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 201   Rest of MEA Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 202   Rest of MEA Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 203   Rest of MEA Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 204   Rest of MEA Companion Diagnostics Market Share, By End User, By Value, 2019–2029

 

List of Tables

 

Table 1        Global Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 2        Global Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 3        Global Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 4        Global Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 5        Global Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 6        Global Companion Diagnostics Market Size, By Region, By Value, 2019–2029

Table 7        North America Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 8        North America Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 9        North America Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 10      North America Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 11      North America Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 12      North America Companion Diagnostics Market Size, By Country, By Value, 2019–2029

Table 13      US Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 14      US Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 15      US Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 16      US Companion Diagnostics Market Size, By Flow Rate, By Value, 2019–2029

Table 17      US Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 18      Canada Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 19      Canada Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 20      Canada Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 21      Canada Companion Diagnostics Market Size, By Flow Rate, By Value, 2019–2029

Table 22      Canada Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 23      Europe Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 24      Europe Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 25      Europe Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 26      Europe Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 27      Europe Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 28      Europe Companion Diagnostics Market Size, By Country, By Value, 2019–2029

Table 29      Germany Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 30      Germany Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 31      Germany Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 32      Germany Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 33      Germany Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 34      UK Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 35      UK Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 36      UK Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 37      UK Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 38      UK Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 39      Italy Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 40      Italy Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 41      Italy Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 42      Italy Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 43      Italy Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 44      France Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 45      France Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 46      France Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 47      France Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 48      France Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 49      Spain Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 50      Spain Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 51      Spain Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 52      Spain Companion Diagnostics Market Size, By Flow Rate, By Value, 2019–2029

Table 53      Spain Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 54      The Netherlands Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 55      The Netherlands Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 56      The Netherlands Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 57      The Netherlands Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 58      The Netherlands Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 59      Rest of Europe Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 60      Rest of Europe Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 61      Rest of Europe Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 62      Rest of Europe Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 63      Rest of Europe Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 64      Asia-Pacific Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 65      Asia-Pacific Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 66      Asia-Pacific Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 67      Asia-Pacific Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 68      Asia-Pacific Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 69      Asia-Pacific Companion Diagnostics Market Size, By Country, By Value, 2019–2029

Table 70      China Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 71      China Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 72      China Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 73      China Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 74      China Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 75      India Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 76      India Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 77      India Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 78      India Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 79      India Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 80      Japan Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 81      Japan Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 82      Japan Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 83      Japan Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 84      Japan Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 85      South Korea Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 86      South Korea Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 87      South Korea Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 88      South Korea Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 89      South Korea Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 90      Australia & New Zealand Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 91      Australia & New Zealand Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 92      Australia & New Zealand Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 93      Australia & New Zealand Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 94      Australia & New Zealand Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 95      Indonesia Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 96      Indonesia Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 97      Indonesia Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 98      Indonesia Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 99      Indonesia Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 100    Malaysia Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 101    Malaysia Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 102    Malaysia Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 103    Malaysia Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 104    Malaysia Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 105    Singapore Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 106    Singapore Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 107    Singapore Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 108    Singapore Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 109    Singapore Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 110    Philippines Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 111    Philippines Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 112    Philippines Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 113    Philippines Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 114    Philippines Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 115    Vietnam Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 116    Vietnam Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 117    Vietnam Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 118    Vietnam Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 119    Vietnam Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 120    Rest of APAC Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 121    Rest of APAC Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 122    Rest of APAC Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 123    Rest of APAC Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 124    Rest of APAC Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 125    Latin America Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 126    Latin America Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 127    Latin America Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 128    Latin America Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 129    Latin America Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 130    Latin America Companion Diagnostics Market Size, By Country, By Value, 2019–2029

Table 131    Brazil Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 132    Brazil Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 133    Brazil Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 134    Brazil Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 135    Brazil Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 136    Mexico Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 137    Mexico Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 138    Mexico Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 139    Mexico Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 140    Mexico Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 141    Argentina Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 142    Argentina Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 143    Argentina Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 144    Argentina Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 145    Argentina Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 146    Peru Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 147    Peru Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 148    Peru Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 149    Peru Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 150    Peru Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 151    Rest of LATAM Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 152    Rest of LATAM Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 153    Rest of LATAM Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 154    Rest of LATAM Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 155    Rest of LATAM Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 156    Middle East & Africa Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 157    Middle East & Africa Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 158    Middle East & Africa Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 159    Middle East & Africa Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 160    Middle East & Africa Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 161    Middle East & Africa Companion Diagnostics Market Size, By Country, By Value, 2019–2029

Table 162    Saudi Arabia Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 163    Saudi Arabia Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 164    Saudi Arabia Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 165    Saudi Arabia Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 166    Saudi Arabia Companion Diagnostics Market Size, By Distribution Indication, By Value, 2019–2029

Table 167    UAE Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 168    UAE Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 169    UAE Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 170    UAE Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 171    UAE Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 172    Qatar Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 173    Qatar Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 174    Qatar Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 175    Qatar Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 176    Qatar Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 177    Kuwait Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 178    Kuwait Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 179    Kuwait Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 180    Kuwait Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 181    Kuwait Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 182    South Africa Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 183    South Africa Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 184    South Africa Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 185    South Africa Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 186    South Africa Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 187    Nigeria Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 188    Nigeria Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 189    Nigeria Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 190    Nigeria Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 191    Nigeria Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 192    Algeria Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 193    Algeria Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 194    Algeria Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 195    Algeria Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 196    Algeria Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 197    Rest of MEA Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 198    Rest of MEA Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 199    Rest of MEA Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 200    Rest of MEA Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 201    Rest of MEA Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 202    Abbott Laboratories Inc. Company Overview

Table 203    Abbott Laboratories Inc. Financial Overview

Table 204    Agilent Technologies Inc. Company Overview

Table 205    Agilent Technologies Inc. Financial Overview

Table 206    F.Hoffmann-La Roche Ltd Company Overview

Table 207    F.Hoffmann-La Roche Ltd Financial Overview

Table 208    Biomerieux SA Company Overview

Table 209    Biomerieux SA Financial Overview

Table 210    Qiagen NV Company Overview

Table 211    Qiagen NV Financial Overview

Table 212    Siemens Healthcare Company Overview

Table 213    Siemens Healthcare Financial Overview

Table 214    Thermo Fisher Scientific Inc. Company Overview

Table 215    Thermo Fisher Scientific Inc. Financial Overview

Table 216    Danaher Corporation (Beckman Coulter Inc.) Company Overview

Table 217    Danaher Corporation (Beckman Coulter Inc.) Financial Overview

Table 218    Almac Group Company Overview

Table 219    Almac Group Financial Overview

Table 220    Illumina Inc. Company Overview

Table 221    Illumina Inc. Financial Overview

Table 222    Myriad Genetics Inc. Company Overview

Table 223    Myriad Genetics Inc. Financial Overview

Table 224    Sysmex Corporation Company Overview

Table 225    Sysmex Corporation Financial Overview

Table 226    Abnova Corporation Company Overview

Table 227    Abnova Corporation Financial Overview

Table 228    Guardant Health Inc Company Overview

Table 229    Guardant Health Inc Financial Overview

Market Segmentation

By Product & Service

  • Assays, Kits & Reagents

  • Software & Services

By Technology

  • Polymerase Chain Reaction

  • Next-generation Sequencing

  • In Situ Hybridization

  • Immunohistochemistry

By Indication

  • Cancer

  • Neurological Disorders

  • Cardiovascular Diseases

  • Infectious Diseases

By End User

  • Pharmaceutical & Biopharmaceutical Companies

  • Reference Laboratories

  • Contract Research Organizations

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America

  • Middle East and Africa (MEA)

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Global Companion Diagnostics Market size was estimated at USD 6.12 billion in 2022.
Ans: Major factors driving the growth of Global Companion Diagnostics Market include increasing cases of adverse drug reactions and co-development of drug and diagnostic technology.
Ans: The assays, kits & reagents segment is expected to hold the highest market share in the Global Companion Diagnostics Market by product and service.
Ans: The polymerase chain reaction segment is expected to hold the highest market share in Global Companion Diagnostics Market by technology.
Ans: Key players in Global Companion Diagnostics Market include Abbott Laboratories Inc., Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Biomerieux SA, Qiagen NV, Siemens Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter Inc.), Almac Group, Illumina Inc., Myriad Genetics Inc., Sysmex Corporation, Abnova Corporation, and Guardant Health Inc. 
array(1) {
  ["__ci_last_regenerate"]=>
  int(1732200013)
}